A clinicopathological study of gestational trophoblastic diseases in a tertiary healthcare centre

Hinaben H. Kakadiya; Arpita J. Nishal; Prachee M. Desai; Ritika H. Viradiya

doi:10.18203/2320-6012.ijrms20252021

Authors

Hinaben H. Kakadiya Department of Pathology, Government Medical College, Surat, Gujarat, India
Arpita J. Nishal Department of Pathology, Government Medical College, Surat, Gujarat, India
Prachee M. Desai Department of Pathology, Government Medical College, Surat, Gujarat, India
Ritika H. Viradiya Department of Pathology, Government Medical College, Surat, Gujarat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20252021

Keywords:

Beta-hCG, Choriocarcinoma, Gestational trophoblastic disease, Hydatidiform mole

Abstract

Background: Gestational trophoblastic diseases are marked by abnormal proliferation of various trophoblastic cells during placentation. It includes hydatidiform mole, invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT). GTNs are among the rare human tumours that can be cured even in the presence of widespread dissemination. Aims of present study was to assess histomorphological features of GTD along with its clinical correlation.

Methods: It was an observational cross-sectional study conducted in the Department of Pathology, at tertiary healthcare centre in South Gujarat over a period of 5 years from January 2019 to December 2023. Histological finding of all cases were recorded and clinical correlation done.

Results: Out of 50 analysed cases of GTDs, 47 cases (94%) were Hydatiform mole and 3 cases (6%) were choriocarcinoma. The incidence of gestational trophoblastic diseases is found to be 1 in 799 pregnancies. Age ranged from 18-35 years. The most commonly affected age group was 20-25 years with 29 cases (58%). Most cases were presented in the first trimester. Most common clinical presentation was bleeding per vagina in 34 cases (68%) followed by abdominal pain. The majority of GTD cases belonged to 50,000 to <1,00,000 mlU/ml beta-HCG level.

Conclusions: Hydatidiform mole is most prevalent gestational trophoblastic disease. Present study signifies the importance of routine histopathological examination of products of conception to rule out microscopic molar changes, since there is an higher incidence of molar pregnancies progressing to choriocarcinoma, a highly metastasizing neoplasm.

Metrics

Metrics Loading ...

References

Sankaran AD, Shanthi AL. Clinicopathological study of gestational trophoblastic diseases. Int J Sci Res. 2015;4(4):230-5.

Lurain JR. Gestational trophoblastic disease: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease and management of hydatidiform mole. Am J Obstet and Gynecol. 2010;203(6):531-39. DOI: https://doi.org/10.1016/j.ajog.2010.06.073

Haines D, Taylor M, Fox H. Haines, Taylor's gynecological pathology. 5th ed. London: Hodder Arnold. 2012: 1359-1416.

WHO Classification of Tumours of the Female Genital Tract. 5th ed. Lyon: Int Agen Res Cancer. 2020: 309-334.

Antaratani RA, Shruthi M. Study of gestational trophoblastic diseases at a tertiary care hospital in India. Int J Report Contracept Obstet Gynecol. 2018;77:1622-7. DOI: https://doi.org/10.18203/2320-1770.ijrcog20181367

Thakuria SK, Deka MK, Sheikh SA. A clinicopathological study of gestational trophoblastic disease in a tertiary care centre of southern Assam. Int J Res Med Sci. 2021;9:1169-73. DOI: https://doi.org/10.18203/2320-6012.ijrms20211370

Jagtap SV, Aher V, Gadhiya S, Jagtap SS. Gestational trophoblastic disease-Clinicopathological study at tertiary care hospital. J Clin Diagnostic Res. 2017;11(8):27. DOI: https://doi.org/10.7860/JCDR/2017/27232.10458

Madan A, Soni S, Upasana, Agrawal K, Neki NS. Incidence and clinical outcome of gestational trophoblastic diseases in a tertiary care hospital. Int J Curr Res Med Sci. 2017;3(8):45-51. DOI: https://doi.org/10.22192/ijcrms.2017.03.08.008

Al Alaf SK, Omer DI. Prevalence and clinical observations of gestational trophoblastic diseases in Maternity Teaching Hospital in Erbil city. WSEAS Transact Biol Biomed. 2010;7(3):87.

Mulik J, Choudhary A. Clinical study of gestational trophoblastic disease in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2020;9:2964-8. DOI: https://doi.org/10.18203/2320-1770.ijrcog20202741

Kumar N, Saxena YK, Rathi AK, Chitra R, Kumar P. Host and risk factors for gestational trophoblastic disease: a hospital based analysis from India. Med Sci Mohit Int Med J Exp Clin Res. 2003;9(10):442-7.

Agrawal N, Sagtani RA, Budhathoki SS, Pokharel HP. Clinico-epidemiological profile of molar pregnancies in a tertiary care centre of Eastern Nepal: A retrospective review of medical records. Gynecologic oncology Res and practice. 2015;2(1):1-7. DOI: https://doi.org/10.1186/s40661-015-0017-y

Obahiagbon I, Ugiagbe EE. Morphological pattern of gestational trophoblastic disease in the University of Benin Teaching Hospital, Benin City: a twenty-year review (1993–2012). J Adv Med Med Res. 2016;19(2):1-7. DOI: https://doi.org/10.9734/BJMMR/2017/29417

Mbamara SU, Obiechina N, Eleje GU, Akabuike CJ, Umeononihu OS. Gestational trophoblastic disease in a tertiary hospital in Nnewi, southeast Nigeria. Niger Med J. 2009;50:87-89.

Shrivastava S, Gandhewar MR. Gestational trophoblastic disease: a profile of 37 cases. Int J Reprod Contracept Obstet Gynecol. 2014;3:317-20. DOI: https://doi.org/10.5455/2320-1770.ijrcog20140605

Fatima M, Kasi PM, Baloch SN, Kassi M, Marri SM, Kassi M. Incidence, management, and outcome of molar pregnancies at a tertiary care hospital in quetta, pakistan. Int Schol Res Not. 2011;2(1):925316. DOI: https://doi.org/10.5402/2011/925316

Benjapibal M, Boriboonhirunsarn D, Suphanit I, Wongtiraporn W, Tosukhowong S, Thirapakawong C. Molar pregnancy: clinical analysis of 151 patients. Thai J Obstet Gynaecol. 2000;6:35-41.

Ocheke AN, Musa J, Uamai AO. Hydatidiform mole in Jos, Nigeria. Nigerian Medical J. 2011;52(4):223-6. DOI: https://doi.org/10.4103/0300-1652.93792